Is there a difference in outcome based on device (product size, primary and secondary embolic material) used?
• There does not appear to be any impact of UAE related to the embolic type, embolic particle type, or other technical aspects of the procedure on adverse events. • The devices used do not appear to affect outcomes at 6 and 12 months after embolization. • Whether subtle differences in the characteristics of the embolic material affect longer term outcome will require analysis of the data from the 24- and 36-month followups. • Are there certain patient subgroups at higher risk or that have an increased likelihood of treatment benefits? • At this time, no subgroups have been identified that had a poor outcome or for whom the procedure would not be recommended. The data suggest that most patients who have symptomatic fibroids will benefit from embolization. • The one strong predictor of clinical failure was unilateral embolization, which was defined at the outset as a technical failure (standard treatment is bilateral embolization). Not surprisingly, the patients with a technically failed
Related Questions
- I have a yellow exclamation sign in my primary and secondary hard disk controller in device manager in Windows 95 and my CD-ROM does not work. What do I do?
- What is the difference between Primary, Secondary & Advanced Secondary effluent quality?
- What is the difference between primary & secondary storage device?
